Harold H. Shlevin, Chief Operating Officer at GALECTIN THERAPEUTICS INC (GALT), sold 119,200 shares at $5.00 ($603K) on 2018-05-31, disclosed to the SEC on 2018-06-04.
Open-market sale of $603k GALT by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.00 | 50,000 | $250K | 41.5% |
| 2 | $5.10 | 69,200 | $353K | 58.5% |
| Total | $5.06 avg | 119,200 | $603K | 100% |
| Filing → |
| GALT | SELL | 2025-12-16 | $354K | — | Filing → |
| GALT | SELL | 2025-12-10 | $1.3M | — | Filing → |
| GALT | BUY | 2024-12-31 | $8K | — | Filing → |